• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.60% Nasdaq Down 0.48%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    25.82 Up 0.31(1.23%) 2:38PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:25.51
    Open:25.38
    Bid:25.74 x 100
    Ask:25.76 x 100
    1y Target Est:30.56
    Beta:1.2
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:24.92 - 26.11
    52wk Range:11.33 - 35.23
    Volume:719,514
    Avg Vol (3m):1,380,430
    Market Cap:1.07B
    P/E (ttm):N/A
    EPS (ttm):-4.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 1.23%1.07B
    ALNYUp 1.22%10.96B
    GSKDown 1.07%107.01B
    ISISUp 0.69%8.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):288.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.89
    Quarterly EPS Est (Jun-15) :-1.21
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):26.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback